Probiotics as Antifungals in Mucosal Candidiasis

Clinical Infectious Diseases

Volumn 62, Issue 9, 2016, Pages 1143-1153

  Matsubara, Victor H ^a,b,c   Bandara, H M H N ^a   Mayer, Marcia P A ^b   Samaranayake, Lakshman P ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Institute of Biomedical Sciences   (Australia)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Candida; candidiasis; Lactobacillus; Probiotics

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; POLYENE; PROBIOTIC AGENT; VORICONAZOLE;

ALTERNATIVE MEDICINE; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDIASIS; CRITICALLY ILL PATIENT; DRUG RESISTANCE; FUNGAL COLONIZATION; GASTROINTESTINAL TRACT; GENE EXPRESSION; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; INVASIVE CANDIDIASIS; LACTOBACILLUS JOHNSONII; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MOUTH INFECTION; MUCOCUTANEOUS CANDIDIASIS; NONHUMAN; PATIENT SAFETY; PRIORITY JOURNAL; SACCHAROMYCES BOULARDII; STOMACH PH; STOMATITIS; STREPTOCOCCUS SALIVARIUS; SYSTEMIC MYCOSIS; THRUSH; UROGENITAL SYSTEM; ADOLESCENT; ADULT; AGED; FEMALE; HUMAN; INFANT; LACTOBACILLUS; MICROBIOLOGY; MIDDLE AGED; NEWBORN; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDIASIS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LACTOBACILLUS; MIDDLE AGED; PROBIOTICS; YOUNG ADULT;

EID: 84966526550     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciw038     Document Type: Article

References (40)

1. Hu H, Merenstein DJ, Wang C, et al. Impact of eating probiotic yogurt on colonization by Candida species of the oral and vaginal mucosa in HIV-infected and HIV-uninfected women. Mycopathologia 2013; 176:175-81.
2. Vicariotto F, Del Piano M, Mogna L, Mogna G. Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study. J Clin Gastroenterol 2012; 46(suppl): S73-80.
3. Demirel G, Celik IH, Erdeve O, Saygan S, Dilmen U, Canpolat FE. Prophylactic Saccharomyces boulardii versus nystatin for the prevention of fungal colonization and invasive fungal infection in premature infants. Eur J Pediatr 2013; 172:1321-6.
4. Samaranayake LP. Superficial oral fungal infections. Curr Opin Dent 1991; 1:415-22.
5. Brzozowski T, Zwolinska-Wcislo M, Konturek PC, et al. Influence of gastric colonization with Candida albicans on ulcer healing in rats: effect of ranitidine, aspirin and probiotic therapy. Scand J Gastroenterol 2005; 40:286-96.
6. Sardi JC, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJ. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol 2013; 62(pt 1):10-24.
7. Saarela M, Mogensen G, Fonden R, Matto J, Mattila-Sandholm T. Probiotic bacteria: safety, functional and technological properties. J Biotechnol 2000; 84:197-215.
8. Shida K, Nomoto K. Probiotics as efficient immunopotentiators: translational role in cancer prevention. Indian J Med Res 2013; 138:808-14.
9. Khalesi S, Sun J, Buys N, Jayasinghe R. Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials. Hypertension 2014; 64:897-903.
10. Jones ML, Tomaro-Duchesneau C, Martoni CJ, Prakash S. Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications. Expert Opin Biol Ther 2013; 13:631-42.
11. Li D, Li Q, Liu C, et al. Efficacy and safety of probiotics in the treatment of Candida-associated stomatitis. Mycoses 2014; 57:141-6.
12. Martinez RC, Franceschini SA, Patta MC, et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett Appl Microbiol 2009; 48:269-74.
13. Coman MM, Verdenelli MC, Cecchini C, et al. In vitro evaluation of antimicrobial activity of Lactobacillus rhamnosus IMC 501®, Lactobacillus paracasei IMC 502® and SYNBIO® against pathogens. J Appl Microbiol 2014; 117:518-27.
14. Hasslöf P, Hedberg M, Twetman S, Stecksen-Blicks C. Growth inhibition of oral mutans streptococci and candida by commercial probiotic lactobacilli-an in vitro study. BMC Oral Health 2010; 10:18.
15. Hatakka K, Ahola AJ, Yli-Knuuttila H, et al. Probiotics reduce the prevalence of oral Candida in the elderly-A randomized controlled trial. J Dent Res 2007; 86:125-30.
16. Ishikawa KH, Mayer MP, Miyazima TY, et al. A multispecies probiotic reduces oral Candida colonization in denture wearers. J Prosthodont 2014; 24:194-9.
17. Kraft-Bodi E, Jorgensen MR, Keller MK, Kragelund C, Twetman S. Effect of probiotic bacteria on oral Candida in frail elderly. J Dent Res 2015; 94:181S-6.
18. Kumar S, Bansal A, Chakrabarti A, Singhi S. Evaluation of efficacy of probiotics in prevention of Candida colonization in a PICU-A randomized controlled trial. Crit Care Med 2013; 41:565-72.
19. Manzoni P, Mostert M, Leonessa ML, et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis 2006; 42:1735-42.
20. Roy A, Chaudhuri J, Sarkar D, Ghosh P, Chakraborty S. Role of enteric supplementation of probiotics on late-onset sepsis by Candida species in preterm low birth weight neonates: a randomized, double blind, placebo-controlled trial. N Am J Med Sci 2014; 6:50-7.
21. Romeo MG, Romeo DM, Trovato L, et al. Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome. J Perinatol 2011; 31:63-9.
22. Lehtoranta L, Pitkaranta A, Korpela R. Probiotics in respiratory virus infections. Eur J Clin Microbiol Infect Dis 2014; 33:1289-302.
23. Ishijima SA, Hayama K, Burton JP, et al. Effect of Streptococcus salivarius K12 on the in vitro growth of Candida albicans and its protective effect in an oral candidiasis model. Appl Environ Microbiol 2012; 78:2190-9.
24. Kheradmand E, Rafii F, Yazdi MH, Sepahi AA, Shahverdi AR, Oveisi MR. The antimicrobial effects of selenium nanoparticle-enriched probiotics and their fermented broth against Candida albicans. Daru 2014; 22:48.
25. Köhler GA, Assefa S, Reid G. Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans. Infect Dis Obstet Gynecol 2012; 2012:636474.
26. Murzyn A, Krasowska A, Stefanowicz P, Dziadkowiec D, Lukaszewicz M. Capric acid secreted by S. boulardii inhibits C. albicans filamentous growth, adhesion and biofilm formation. PLoS One 2010; 5:e12050.
27. Strus M, Kucharska A, Kukla G, Brzychczy-Wloch M, Maresz K, Heczko PB. The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida. Infect Dis Obstet Gynecol 2005; 13:69-75.
28. Thein ZM, Samaranayake YH, Samaranayake LP. Effect of oral bacteria on growth and survival of Candida albicans biofilms. Arch Oral Biol 2006; 51:672-80.
29. Ujaoney S, Chandra J, Faddoul F, et al. In vitro effect of over-the-counter probiotics on the ability of Candida albicans to form biofilm on denture strips. J Dent Hyg 2014; 88:183-9.
30. Verdenelli MC, Coman MM, Cecchini C, Silvi S, Orpianesi C, Cresci A. Evaluation of antipathogenic activity and adherence properties of human Lactobacillus strains for vaginal formulations. J Appl Microbiol 2014; 116:1297-307.
31. Vilela SF, Barbosa JO, Rossoni RD, et al. Lactobacillus acidophilus ATCC 4356 inhibits biofilm formation by C. albicans and attenuates the experimental candidiasis in Galleria mellonella. Virulence 2015; 6:29-39.
32. Chew SY, Cheah YK, Seow HF, Sandai D, Than LT. Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 exhibit strong antifungal effects against vulvovaginal candidiasis-causing Candida glabrata isolates. J Appl Microbiol 2015; 118:1180-90.
33. Sutula J, Coulthwaite L, Thomas L, Verran J. The effect of a commercial probiotic drink on oral microbiota in healthy complete denture wearers. Microb Ecol Health Dis 2012; 23.
34. Sutula J, Coulthwaite LA, Thomas LV, Verran J. The effect of a commercial probiotic drink containing Lactobacillus casei strain Shirota on oral health in healthy dentate people. Microb Ecol Health Dis 2013; 24.
35. Kovachev SM, Vatcheva-Dobrevska RS. Local probiotic therapy for vaginal Candida albicans infections. Probiotics Antimicrob Proteins 2015; 7:38-44.
36. Wagner RD, Johnson SJ. Probiotic lactobacillus and estrogen effects on vaginal epithelial gene expression responses to Candida albicans. J Biomed Sci 2012; 19:58.
37. Zakaria Gomaa E. Antimicrobial and anti-adhesive properties of biosurfactant produced by lactobacilli isolates, biofilm formation and aggregation ability. J Gen Appl Microbiol 2013; 59:425-36.
38. Pirotta M, Gunn J, Chondros P, et al. Effect of Lactobacillus in preventing postantibiotic vulvovaginal candidiasis: a randomised controlled trial. BMJ 2004; 329:548.
39. Mendoncą FH, Santos SS, Faria Ida S, Goncalves e Silva CR, Jorge AO, Leao MV. Effects of probiotic bacteria on Candida presence and IgA anti-Candida in the oral cavity of elderly. Braz Dent J 2012; 23:534-8.
40. Gantner BN, Simmons RM, Underhill DM. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J 2005; 24:1277-86.